IDH2 and neoplasm: As a further line of interest, the detection of elevated D2HG concentrations in different tumor entities may identify elevated D2HG levels as a surrogate marker, eventually in combination with the distribution of lactate, for tumor-relevant IDH1 and IDH2 mutations (3).